These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2408336)

  • 1. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.
    Milich DR; Thornton GB; Neurath AR; Kent SB; Michel ML; Tiollais P; Chisari FV
    Science; 1985 Jun; 228(4704):1195-9. PubMed ID: 2408336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region.
    Milich DR; McNamara MK; McLachlan A; Thornton GB; Chisari FV
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8168-72. PubMed ID: 2415982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.
    Milich DR; McLachlan A; Chisari FV; Kent SB; Thorton GB
    J Immunol; 1986 Jul; 137(1):315-22. PubMed ID: 2423607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame.
    Wong DT; Nath N; Sninsky JJ
    J Virol; 1985 Jul; 55(1):223-31. PubMed ID: 2409297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.
    Milich DR; Jones JE; McLachlan A; Bitter G; Moriarty A; Hughes JL
    J Immunol; 1990 May; 144(9):3544-51. PubMed ID: 1691763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus contains pre-S gene-encoded domains.
    Neurath AR; Kent SB; Strick N; Taylor P; Stevens CE
    Nature; 1985 May 9-15; 315(6015):154-6. PubMed ID: 2581144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity.
    Milich DR; Hughes JL; McLachlan A; Langley KE; Thornton GB; Jones JE
    J Immunol; 1990 May; 144(9):3535-43. PubMed ID: 1691762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
    Milich DR; Leroux-Roels GG; Louie RE; Chisari FV
    J Exp Med; 1984 Jan; 159(1):41-56. PubMed ID: 6198427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to hepatitis B virus proteins: relevance of the murine model.
    Milich DR
    Semin Liver Dis; 1991 May; 11(2):93-112. PubMed ID: 1832237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
    Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.
    Milich DR; Peterson DL; Leroux-Roels GG; Lerner RA; Chisari FV
    J Immunol; 1985 Jun; 134(6):4203-11. PubMed ID: 2580909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
    Milich DR; Chisari FV
    J Immunol; 1982 Jul; 129(1):320-5. PubMed ID: 6177755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
    Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments.
    Heermann KH; Kruse F; Seifer M; Gerlich WH
    Intervirology; 1987; 28(1):14-25. PubMed ID: 2448264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunoassay of pre-S gene-coded sequences in hepatitis B vaccines.
    Neurath AR; Strick N; Kent SB; Offensperger W; Wahl S; Christman JK; Acs G
    J Virol Methods; 1985 Dec; 12(3-4):185-92. PubMed ID: 2422192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination.
    Marescot MR; Budkowska A; Pillot J; Debre P
    Tissue Antigens; 1989 May; 33(5):495-500. PubMed ID: 2477913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
    Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
    J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
    Tam JP; Lu YA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9084-8. PubMed ID: 2480595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.